Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque
Jin-Hyuk JANG; Ji-Kan RYU; Jun-Kyu SUH.
Korean Journal of Urology
; : 44-49, 2012.
Artículo en Inglés | WPRIM | ID: wpr-106965
Documentos relacionados
Dorsal-Ventral Gradient of Activin Regulates Strength of GABAergic Inhibition along Longitudinal Axis of Mouse Hippocampus in an Activity-Dependent Fashion.
Activin E is a transforming growth factor ß ligand that signals specifically through activin receptor-like kinase 7.
Ligand trap for the activin type IIA receptor. The long-sought drug to overcome the calcification paradox in CKD?
Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?
Anabolic Medications for Muscle Wasting in Chronic Obstructive Pulmonary Disease. Is the Evidence Getting Stronger?
Principles of the activin receptor signaling pathway and its inhibition.
Steps toward therapeutically targeting the activin type II receptor for treating heart failure.
Blocking the activin IIB receptor with bimagrumab (BYM338) increases walking performance: A meta-analysis.
The orphan ligand, activin C, signals through activin receptor-like kinase 7.
Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.